Search research articles
Contact Us
Filters
Showing results (71-80 of 104) with videos related to
Page
of 11
Sort By:
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
November 1, 1990
[Expression of hepatitis B virus (HBV) markers in chronic liver disease positive for antibody to hepatitis C virus (HCV)]
N Yuki, N Hayashi, A Kasahara, et al.
Cancer
|
March 1, 1977
Carcinoembryonic antigen, alpha-fetoprotein and carcinoplacental alkaline phosphatase in gastric carcinoma metastatic to the liver
M Masuzawa, P K Lee, T Kamada, et al.
Journal of Hepatology
|
September 1, 1993
Clinical applications of ICG Finger Monitor in patients with liver disease
Y Ishigami, M Masuzawa, E Miyoshi, et al.
Journal of Medical Virology
|
July 1, 1995
Long-term follow-up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients coinfected with both viruses
K Ohkawa, N Hayashi, N Yuki, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Effects of transcatheter arterial chemoembolization with oral chemotherapy on hepatic neoplasms
N Hashimoto, S Kawai, S Mikuriya, et al.
Journal of Hepatology
|
October 1, 1994
Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients
K Ohkawa, N Hayashi, N Yuki, et al.
Hepatology (Baltimore, Md.)
|
February 1, 1995
Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial
A Kasahara, N Hayashi, N Hiramatsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 1, 1990
[Lipiodol transcatheter arterial chemoembolization for non-resectable hepatocellular carcinoma--multicenter cooperative study]
S Kawai, M Tani, S Mikuriya, et al.
Scandinavian Journal of Gastroenterology
|
October 1, 1996
Treatment with recombinant interferon-alpha 2a for patients with chronic hepatitis C: predictive factors for biochemical and virologic response. Osaka Liver Disease Study Group
H Hagiwara, N Hayashi, A Kasahara, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
November 1, 1989
[Development and clinical application of ICG clearance meter]
Y Ishigami, E Miyoshi, M Masuzawa, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 104) with videos related to
Sort By:
Page
of 11
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
November 1, 1990
[Expression of hepatitis B virus (HBV) markers in chronic liver disease positive for antibody to hepatitis C virus (HCV)]
N Yuki, N Hayashi, A Kasahara, et al.
Cancer
|
March 1, 1977
Carcinoembryonic antigen, alpha-fetoprotein and carcinoplacental alkaline phosphatase in gastric carcinoma metastatic to the liver
M Masuzawa, P K Lee, T Kamada, et al.
Journal of Hepatology
|
September 1, 1993
Clinical applications of ICG Finger Monitor in patients with liver disease
Y Ishigami, M Masuzawa, E Miyoshi, et al.
Journal of Medical Virology
|
July 1, 1995
Long-term follow-up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients coinfected with both viruses
K Ohkawa, N Hayashi, N Yuki, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Effects of transcatheter arterial chemoembolization with oral chemotherapy on hepatic neoplasms
N Hashimoto, S Kawai, S Mikuriya, et al.
Journal of Hepatology
|
October 1, 1994
Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients
K Ohkawa, N Hayashi, N Yuki, et al.
Hepatology (Baltimore, Md.)
|
February 1, 1995
Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial
A Kasahara, N Hayashi, N Hiramatsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 1, 1990
[Lipiodol transcatheter arterial chemoembolization for non-resectable hepatocellular carcinoma--multicenter cooperative study]
S Kawai, M Tani, S Mikuriya, et al.
Scandinavian Journal of Gastroenterology
|
October 1, 1996
Treatment with recombinant interferon-alpha 2a for patients with chronic hepatitis C: predictive factors for biochemical and virologic response. Osaka Liver Disease Study Group
H Hagiwara, N Hayashi, A Kasahara, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
November 1, 1989
[Development and clinical application of ICG clearance meter]
Y Ishigami, E Miyoshi, M Masuzawa, et al.
Page
of 11